| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |